Development of Novel Inhibitors for Histone Methyltransferase SET7/9 based on Cyproheptadine

Author:

Hirano Tomoya1ORCID,Fujiwara Takashi1,Niwa Hideaki2ORCID,Hirano Michitake1,Ohira Kasumi1,Okazaki Yusuke1,Sato Shin2,Umehara Takashi2ORCID,Maemoto Yuki3,Ito Akihiro34,Yoshida Minoru456,Kagechika Hiroyuki1ORCID

Affiliation:

1. Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai Chiyoda-ku Tokyo 101-0062 Japan

2. Epigenetics Drug Discovery Unit RIKEN Center for Life Science Technologies (CLST) 1-7-22 Suehiro-cho, Tsurumi-ku Yokohama 230-0045 Japan

3. School of Life Sciences Tokyo University of Pharmacy and Life Sciences 1432-1 Horinouchi Hachioji Tokyo 192-0392 Japan

4. Chemical Genomics Research Group RIKEN Center for Sustainable Resource Science (CSRS) 2-1 Hirosawa Wako Saitama 351-0198 Japan

5. Drug Discovery Platforms Cooperation Division RIKEN Center for Sustainable Resource Science (CSRS) 2-1 Hirosawa Wako Saitama 351-0198 Japan

6. Graduate School of Agricultural and Life Sciences The University of Tokyo 1-1-1 Yayoi Bunkyo-ku Tokyo 113-8657 Japan

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3